Anoshe Aslam1, Jessica Singh1, Elizabeth Robilotti1,2, Karin Chow1, Tarun Bist2, Diane Reidy-Lagunes3, Monika Shah2, Deborah Korenstein4, N Esther Babady2,5, Mini Kamboj1,2. 1. Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 2. Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 3. Gastrointestinal Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 4. General Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 5. Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Abstract
BACKGROUND: New York City (NYC) experienced a surge of coronavirus disease 2019 (COVID-19) cases in March and April 2020. Since then, universal polymerase chain reaction (PCR)-based surveillance testing and personal protective equipment (PPE) measures are in wide use in procedural settings. There is limited published experience on the utility and sustainability of PCR-based surveillance testing in areas with receding and consistently low community COVID-19 rates. METHODS: The study was conducted at a tertiary care cancer center in NYC from 22 March to 22 August 2020. Asymptomatic patients underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing before surgeries, interventional radiology procedures, and endoscopy. Contact tracing in procedural areas was done if a patient with an initial negative screen retested positive within 48 hours of the procedure. RESULTS: From March 22 until August 22, 2020, 11 540 unique patients underwent 14 233 tests before surgeries or procedures at Memorial Sloan Kettering Cancer Center. Overall, 65 patients were positive, with a peak rate of 4.3% that fell below 0.3% after April 2020. Among the 65 positive cases, 3 were presymptomatic and 38 were asymptomatic. Among asymptomatic test-positive patients, 76% had PCR cycle threshold >30 at first detection. Five patients tested newly positive in the immediate postoperative period, exposing 82 employees with 1 case of probable transmission (1.2%). CONCLUSIONS: The prevalence of SARS-CoV-2 infection identified on preprocedural surveillance was low in our study, which was conducted in an area with limited community spread at the later stage of the study. Universal PPE is protective in procedural settings. Optimal and flexible diagnostic strategies are needed to accomplish and sustain the goals of comprehensive preprocedure surveillance testing.
BACKGROUND: New York City (NYC) experienced a surge of coronavirus disease 2019 (COVID-19) cases in March and April 2020. Since then, universal polymerase chain reaction (PCR)-based surveillance testing and personal protective equipment (PPE) measures are in wide use in procedural settings. There is limited published experience on the utility and sustainability of PCR-based surveillance testing in areas with receding and consistently low community COVID-19 rates. METHODS: The study was conducted at a tertiary care cancer center in NYC from 22 March to 22 August 2020. Asymptomatic patients underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing before surgeries, interventional radiology procedures, and endoscopy. Contact tracing in procedural areas was done if a patient with an initial negative screen retested positive within 48 hours of the procedure. RESULTS: From March 22 until August 22, 2020, 11 540 unique patients underwent 14 233 tests before surgeries or procedures at Memorial Sloan Kettering Cancer Center. Overall, 65 patients were positive, with a peak rate of 4.3% that fell below 0.3% after April 2020. Among the 65 positive cases, 3 were presymptomatic and 38 were asymptomatic. Among asymptomatic test-positive patients, 76% had PCR cycle threshold >30 at first detection. Five patients tested newly positive in the immediate postoperative period, exposing 82 employees with 1 case of probable transmission (1.2%). CONCLUSIONS: The prevalence of SARS-CoV-2 infection identified on preprocedural surveillance was low in our study, which was conducted in an area with limited community spread at the later stage of the study. Universal PPE is protective in procedural settings. Optimal and flexible diagnostic strategies are needed to accomplish and sustain the goals of comprehensive preprocedure surveillance testing.
Authors: Ghady Haidar; Ashley Ayres; Wendy C King; Mackenzie McDonald; Alan Wells; Stephanie L Mitchell; Andrew L Bilderback; Tami Minnier; John W Mellors Journal: Open Forum Infect Dis Date: 2021-01-18 Impact factor: 3.835
Authors: Philippe Gorphe; Bruno Grandbastien; Andreas Dietz; Umamaheswar Duvvuri; Robert L Ferris; Wojciech Golusinski; Floyd Christopher Holsinger; Sefik Hosal; George Lawson; Hisham Mehanna; Vinidh Paleri; Richard Shaw; Giovanni Succo; C René Leemans; Christian Simon Journal: Front Oncol Date: 2021-03-24 Impact factor: 6.244
Authors: Iain R Konigsberg; Bret Barnes; Monica Campbell; Elizabeth Davidson; Yingfei Zhen; Olivia Pallisard; Meher Preethi Boorgula; Corey Cox; Debmalya Nandy; Souvik Seal; Kristy Crooks; Evan Sticca; Genelle F Harrison; Andrew Hopkinson; Alexis Vest; Cosby G Arnold; Michael G Kahn; David P Kao; Brett R Peterson; Stephen J Wicks; Debashis Ghosh; Steve Horvath; Wanding Zhou; Rasika A Mathias; Paul J Norman; Rishi Porecha; Ivana V Yang; Christopher R Gignoux; Andrew A Monte; Alem Taye; Kathleen C Barnes Journal: Commun Med (Lond) Date: 2021-10-26
Authors: Orly Ardon; Victor E Reuter; Meera Hameed; Lorraine Corsale; Allyne Manzo; Sahussapont J Sirintrapun; Peter Ntiamoah; Evangelos Stamelos; Peter J Schueffler; Christine England; David S Klimstra; Matthew G Hanna Journal: Acad Pathol Date: 2021-04-28
Authors: Ana Requena-Méndez; Aikaterini Mougkou; Pontus Hedberg; Suzanne D van der Werff; Hideyuki Tanushi; Olof Hertting; Anna Färnert; Filippa Nyberg; Pontus Naucler Journal: Euro Surveill Date: 2022-02